Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders. Indian Journal of Public Health Research & Development, [S. l.], v. 11, n. 8, p. 206–213, 2020. DOI: 10.37506/ijphrd.v11i8.10923. Disponível em: https://medicopublication.com/index.php/ijphrd/article/view/10923. Acesso em: 6 jun. 2026.